74 related articles for article (PubMed ID: 1988641)
1. 20-[18F]fluoromibolerone, a positron-emitting radiotracer for androgen receptors: synthesis and tissue distribution studies.
Liu AJ; Katzenellenbogen JA; VanBrocklin HF; Mathias CJ; Welch MJ
J Nucl Med; 1991 Jan; 32(1):81-8. PubMed ID: 1988641
[TBL] [Abstract][Full Text] [Related]
2. Fluorine-18-labeled androgens: radiochemical synthesis and tissue distribution studies on six fluorine-substituted androgens, potential imaging agents for prostatic cancer.
Liu A; Dence CS; Welch MJ; Katzenellenbogen JA
J Nucl Med; 1992 May; 33(5):724-34. PubMed ID: 1569482
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of the selectivity and efficiency of target tissue uptake of five tritium-labeled androgens in the rat.
Carlson KE; Katzenellenbogen JA
J Steroid Biochem; 1990 Aug; 36(6):549-61. PubMed ID: 2214772
[TBL] [Abstract][Full Text] [Related]
4. Preclinical evaluation of fluorine-18-labeled androgen receptor ligands in baboons.
Bonasera TA; O'Neil JP; Xu M; Dobkin JA; Cutler PD; Lich LL; Choe YS; Katzenellenbogen JA; Welch MJ
J Nucl Med; 1996 Jun; 37(6):1009-15. PubMed ID: 8683293
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of high affinity fluorine-substituted ligands for the androgen receptor. Potential agents for imaging prostatic cancer by positron emission tomography.
Liu A; Carlson KE; Katzenellenbogen JA
J Med Chem; 1992 May; 35(11):2113-29. PubMed ID: 1597861
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of 11 beta-[18F]fluoro-5 alpha-dihydrotestosterone and 11 beta-[18F]fluoro-19-nor-5 alpha-dihydrotestosterone: preparation via halofluorination-reduction, receptor binding, and tissue distribution.
Choe YS; Lidström PJ; Chi DY; Bonasera TA; Welch MJ; Katzenellenbogen JA
J Med Chem; 1995 Mar; 38(5):816-25. PubMed ID: 7877147
[TBL] [Abstract][Full Text] [Related]
7. 21-[18F]fluoro-16 alpha-ethyl-19-norprogesterone: synthesis and target tissue selective uptake of a progestin receptor based radiotracer for positron emission tomography.
Pomper MG; Katzenellenbogen JA; Welch MJ; Brodack JW; Mathias CJ
J Med Chem; 1988 Jul; 31(7):1360-3. PubMed ID: 3260285
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of a fluorine-18-labeled nonsteroidal androgen receptor antagonist, N-(3-[18F]fluoro-4-nitronaphthyl)-cis-5-norbornene-endo-2,3-dicarboxylic imide.
Parent EE; Dence CS; Sharp TL; Welch MJ; Katzenellenbogen JA
Nucl Med Biol; 2006 Jul; 33(5):615-24. PubMed ID: 16843836
[TBL] [Abstract][Full Text] [Related]
9. 7 alpha-Methyl-17 alpha-(E-2'-[125I]iodovinyl)-19-nortestosterone: a new radioligand for the detection of androgen receptor.
Hoyte RM; Brown TJ; MacLusky NJ; Hochberg RB
Steroids; 1993 Jan; 58(1):13-23. PubMed ID: 8430441
[TBL] [Abstract][Full Text] [Related]
10. 7alpha,11beta-Dimethyl-19-nortestosterone: a potent and selective androgen response modulator with prostate-sparing properties.
Cook CE; Kepler JA
Bioorg Med Chem Lett; 2005 Feb; 15(4):1213-6. PubMed ID: 15686944
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of the 7alpha-cyano-(17alpha,20E/Z)-[125I]iodovinyl-19-nortestosterones: potential radioligands for androgen and progesterone receptors.
Ali H; Rousseau J; Ahmed N; Guertin V; Hochberg RB; van Lier JE
Steroids; 2003 Dec; 68(14):1163-71. PubMed ID: 14643878
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and basic evaluation of 7α-(3-[
Okamoto M; Naka K; Ishiwata K; Shimizu I; Toyohara J
Ann Nucl Med; 2017 Jan; 31(1):53-62. PubMed ID: 27680022
[TBL] [Abstract][Full Text] [Related]
13. N-(3-[18F]fluoropropyl)-N-nordiprenorphine: synthesis and characterization of a new agent for imaging opioid receptors with positron emission tomography.
Chesis PL; Hwang DR; Welch MJ
J Med Chem; 1990 May; 33(5):1482-90. PubMed ID: 2158564
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of (17 alpha,20E/Z)iodovinyl testosterone and 19-nortestosterone derivatives as potential radioligands for androgen and progesterone receptors.
Ali H; Rousseau AJ; van Lier JE
J Steroid Biochem Mol Biol; 1994 May; 49(1):15-29. PubMed ID: 8003436
[TBL] [Abstract][Full Text] [Related]
15. Development of [F-18]fluorine-substituted Tanaproget as a progesterone receptor imaging agent for positron emission tomography.
Lee JH; Zhou HB; Dence CS; Carlson KE; Welch MJ; Katzenellenbogen JA
Bioconjug Chem; 2010 Jun; 21(6):1096-104. PubMed ID: 20496889
[TBL] [Abstract][Full Text] [Related]
16. N-3-[18F]fluoropropylputrescine as potential PET imaging agent for prostate and prostate derived tumors.
Hwang DR; Lang LX; Mathias CJ; Kadmon D; Welch MJ
J Nucl Med; 1989 Jul; 30(7):1205-10. PubMed ID: 2500502
[TBL] [Abstract][Full Text] [Related]
17. Fluorinated androgens and progestins: molecular probes for androgen and progesterone receptors with potential use in positron emission tomography.
Brandes SJ; Katzenellenbogen JA
Mol Pharmacol; 1987 Sep; 32(3):391-403. PubMed ID: 3499564
[TBL] [Abstract][Full Text] [Related]
18. Preclinical evaluation of a positron emitting progestin ([18F]fluoro-16 alpha-methyl-19-norprogesterone) for imaging progesterone receptor positive tumours with positron emission tomography.
Verhagen A; Luurtsema G; Pesser JW; de Groot TJ; Wouda S; Oosterhuis JW; Vaalburg W
Cancer Lett; 1991 Aug; 59(2):125-32. PubMed ID: 1884369
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of fluorine-18 21-fluoroprednisone as a potential ligand for neuro-PET studies.
Feliu AL; Rottenberg DA
J Nucl Med; 1987 Jun; 28(6):998-1005. PubMed ID: 3495649
[TBL] [Abstract][Full Text] [Related]
20. Fluorine-18-altanserin: a radioligand for the study of serotonin receptors with PET: radiolabeling and in vivo biologic behavior in rats.
Lemaire C; Cantineau R; Guillaume M; Plenevaux A; Christiaens L
J Nucl Med; 1991 Dec; 32(12):2266-72. PubMed ID: 1744713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
